Aziz Kabeer's Insider Transaction of AN2 Therapeutics, Inc. Common Stock

This filing details a transaction by Aziz Kabeer, a director at AN2 Therapeutics, Inc. On April 10, 2026, Mr. Kabeer acquired 3,775 shares of common stock, valued at $0 per share, under the company's non-employee director compensation policy. These shares vest immediately. Following this transaction, Mr. Kabeer's holdings include 1,995,958 shares held indirectly through Adjuvant Global Health Technology Fund, L.P., and 377,542 shares held indirectly through Adjuvant Global Health Technology Fund DE, L.P. The filing clarifies that Mr. Kabeer, as Secretary of Adjuvant Capital Management, L.L.C., may be deemed to share voting and dispositive power over these securities, but disclaims beneficial ownership beyond his pecuniary interest.